跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
迪分® - NMPA Drug Approval Details
Approvals
/
NMPA
/
Perflutren Lipid Microsphere Injection
Approved
化学药品
Perflutren Lipid Microsphere Injection
Lantheus Mi Canada, Inc.
🇨🇳 National Medical Products Administration
Approval Date
Nov 15, 2022
Approval ID
b9cbe7cb78beca4b
Company
Lantheus Mi Canada, Inc.
Type
化学药品
Approval Details
Approval Id
b9cbe7cb78beca4b
Approval Number
国药准字HJ20220082
Generic Name
八氟丙烷脂质微球注射液
Generic Name En
Perflutren Lipid Microsphere Injection
Trade Name
迪分®
Drug Type
化学药品
Dosage Form
注射剂
Strength
活化前每1ml上层气体中含八氟丙烷6.52mg,活化后每瓶1.5ml乳液中含八氟丙烷225μl
Reg Date
2022-11-15
Expired Date
2027-11-14
Company Name
Lantheus Mi Canada, Inc.
Production Company Name
JUBILANT HOLLISTERSTIER LLC
Company Detail Path
/organization/lantheus-mi-canada-inc
Production Company Detail Path
/organization/jubilant-hollisterstier-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 15, 2022
Approval ID
b9cbe7cb78beca4b
Type
化学药品
Back to NMPA Approvals